weaning off tirzepatide GLP-1 Medications: A Sustainable Approach My Entire Tirzepatide GLP-1 Weight

Wegovy pill: first oral GLP-1 approved for weight loss In a landmark development, the FDA approved the Wegovy pill (oral semaglutide 25 mg) on December 22, 2025 , making it the worlds first oral GLP-1 receptor agonist approved specifically for weight management a major shift from the injection-only landscape [8]

Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain

Importantly, Mahsa emphasizes that even with treatment, flares can still trigger severe headaches and that many doctors underestimate their connection to IgG4-RD

Patients treated with semaglutide or any GLP-1 analogue in combination with a sulphonylurea or insulin may have an increased risk of hypoglycaemia (low blood glucose of less than 4mmol/l or 72mg/dl)

For a Mounjaro-specific guide, see what to eat on Mounjaro